Clinical Trials Logo

First or Second Line Therapy clinical trials

View clinical trials related to First or Second Line Therapy.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01238029 Terminated - Clinical trials for Metastatic Breast Cancer

Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer

CELAVIE
Start date: October 2010
Phase: Phase 1
Study type: Interventional

The purpose of the study is to investigate safety and efficiency of the triple combination of capecitabine, lapatinib and vinorelbine in patients with metastatic breast cancer.